Natriumklorid-Glucos, Viaflo Baxter (Sodium Chloride, Glucose)

Sodium chloride, the active ingredient in Natriumklorid-Glucos, is an electrolyte solution presented as an injectable solution for intravenous use. It restores extracellular fluid volume, provides sodium and chloride for electrolyte balance, and supplies glucose as an energy substrate, making it suitable for patients who need fluid replacement, peri‑operative hydration, or prevention of hypoglycaemia. GNH USA supplies Natriumklorid-Glucos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to healthcare facilities across multiple regions.

Natriumklorid-Glucos is an intravenous electrolyte solution used in clinical situations that require rapid fluid and electrolyte restoration. - Fluid replacement: restores intravascular volume and corrects dehydration. - Electrolyte balance: supplies sodium and chloride to maintain plasma electrolyte concentrations. - Prevention or treatment of hypoglycaemia: provides glucose as an immediate energy source. - Peri‑operative hydration: supports patients undergoing surgery by maintaining circulatory stability.

Adverse reactions may occur with any intravenous therapy and should be monitored.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Hypernatremia: elevated serum sodium if administered excessively. - Hyperglycemia: transient rise in blood glucose levels. - Hypotension: drop in blood pressure due to rapid volume shifts. - Allergic reaction: rash or urticaria at the site.

Serious or Rare Side Effects: - Anaphylaxis: severe, life‑threatening allergic response. - Severe hypernatremia leading to seizures. - Fluid overload causing pulmonary edema. - Electrolyte imbalance resulting in cardiac arrhythmia.

Use of Natriumklorid-Glucos requires careful clinical assessment and monitoring. - Renal impairment: adjust volume and monitor electrolytes closely. - Cardiac failure: avoid fluid overload; assess cardiac function. - Hyperglycemia: monitor blood glucose in diabetic patients. - Electrolyte disorders: correct severe abnormalities before infusion. - Pregnancy: only if potential benefit justifies the risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intravenous electrolyte solutions can interact with other agents that affect fluid or electrolyte status.

Major Interactions (Avoid): - Hypertonic saline solutions: risk of severe hypernatremia. - Insulin therapy: may cause rapid shifts in glucose levels. - Loop diuretics: can exacerbate electrolyte loss.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycaemia. - ACE inhibitors: monitor renal function and potassium. - Corticosteroids: increase risk of hyperglycaemia.